View in EDS

Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer.

Saved in:
Bibliographic Details
Title: Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer.
Authors: Owiredu J; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Ersoy-Fazlioglu B; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Poluben L; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Calagua C; Department of Pathology, Mount Sinai, New York, New York., Dennehy C; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Stavridi AM; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Wang L; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Voznesensky O; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Xie F; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Ye H; Department of Pathology, Cedars Sinai Medical Center, Los Angeles, California., Sun Y; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Einstein DJ; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Gao X; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts., Mantia C; Division of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Taplin ME; Division of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Muller WJ; Goodman Cancer Research Centre, McGill University, Montreal, Canada., Balk SP; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Russo JW; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Nov 03; Vol. 31 (21), pp. 4598-4610.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40795068
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Owiredu+J%22">Owiredu J</searchLink>; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ersoy-Fazlioglu+B%22">Ersoy-Fazlioglu B</searchLink>; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Poluben+L%22">Poluben L</searchLink>; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Calagua+C%22">Calagua C</searchLink>; Department of Pathology, Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Dennehy+C%22">Dennehy C</searchLink>; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Stavridi+AM%22">Stavridi AM</searchLink>; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Voznesensky+O%22">Voznesensky O</searchLink>; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Xie+F%22">Xie F</searchLink>; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ye+H%22">Ye H</searchLink>; Department of Pathology, Cedars Sinai Medical Center, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Sun+Y%22">Sun Y</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Einstein+DJ%22">Einstein DJ</searchLink>; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Gao+X%22">Gao X</searchLink>; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Mantia+C%22">Mantia C</searchLink>; Division of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Taplin+ME%22">Taplin ME</searchLink>; Division of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Muller+WJ%22">Muller WJ</searchLink>; Goodman Cancer Research Centre, McGill University, Montreal, Canada.<br /><searchLink fieldCode="AU" term="%22Balk+SP%22">Balk SP</searchLink>; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Russo+JW%22">Russo JW</searchLink>; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2025 Nov 03; Vol. 31 (21), pp. 4598-4610.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40795068
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-22-3683
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4598
    Titles:
      – TitleFull: Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Owiredu J
      – PersonEntity:
          Name:
            NameFull: Ersoy-Fazlioglu B
      – PersonEntity:
          Name:
            NameFull: Poluben L
      – PersonEntity:
          Name:
            NameFull: Calagua C
      – PersonEntity:
          Name:
            NameFull: Dennehy C
      – PersonEntity:
          Name:
            NameFull: Stavridi AM
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Voznesensky O
      – PersonEntity:
          Name:
            NameFull: Xie F
      – PersonEntity:
          Name:
            NameFull: Ye H
      – PersonEntity:
          Name:
            NameFull: Sun Y
      – PersonEntity:
          Name:
            NameFull: Einstein DJ
      – PersonEntity:
          Name:
            NameFull: Gao X
      – PersonEntity:
          Name:
            NameFull: Mantia C
      – PersonEntity:
          Name:
            NameFull: Taplin ME
      – PersonEntity:
          Name:
            NameFull: Muller WJ
      – PersonEntity:
          Name:
            NameFull: Balk SP
      – PersonEntity:
          Name:
            NameFull: Russo JW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 11
              Text: 2025 Nov 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 21
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1